4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-23-016041
President & CEO gave up 16,140 shares (to pay taxes)
- President & CEO acquired 54,916 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| KAKKIS EMIL D President & CEO | 2023-03-01 | Grant or award | +8,716 | 569,406 | D | ||
| KAKKIS EMIL D President & CEO | 2023-03-01 | Grant or award | +46,200 | 615,606 | D | ||
| KAKKIS EMIL D President & CEO | 2023-03-01 | Shares withheld for taxes | −16,140 | $45.65 | $736,791 | 599,176 | D |
| Derivatives | |||||||
| KAKKIS EMIL D President & CEO | 2023-03-01 | Grant or award · Stock Option (Right to Buy) | +83,500 | 83,500 | D | ||
Loading xslF345X03/doc4.xml…